Performance of UTHR United Therapeutics | 57.1% in 12m
Compare UTHR with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare United Therapeutics with its related Sector/Index XBI
Performance Duell UTHR vs XBI
| TimeFrame | UTHR | XBI |
|---|---|---|
| 1 Week | -4.70% | -3.57% |
| 1 Month | -0.85% | -2.54% |
| 3 Months | 4.70% | -3.08% |
| 6 Months | 50.4% | 14.30% |
| 12 Months | 57.1% | 46.30% |
| YTD | 55.1% | 7.29% |
| Rel. Perf. 1m | 0.36 | |
| Rel. Perf. 3m | 2.13 | |
| Rel. Perf. 6m | 2.75 | |
| Rel. Perf. 12m | 0.89 | |
| Spearman 1m | 0.34 | 0.261 |
| Spearman 3m | 0.79 | 0.027 |
Is United Therapeutics a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, United Therapeutics (NASDAQ:UTHR) is currently (October 2024)
a good stock to buy. It has a ValueRay Fundamental Rating of 75.80 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of UTHR as of October 2024 is 430.84. This means that UTHR is currently undervalued and has a potential upside of +22.2% (Margin of Safety).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of UTHR as of October 2024 is 430.84. This means that UTHR is currently undervalued and has a potential upside of +22.2% (Margin of Safety).
Is UTHR a buy, sell or hold?
- Strong Buy: 7
- Buy: 2
- Hold: 5
- Sell: 2
- Strong Sell: 0
Values above 0%: UTHR is performing better - Values below 0%: UTHR is underperforming
Compare UTHR with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -3.96% | -2.31% | 35.34% | 15.12% |
| US NASDAQ 100 | QQQ | -4.18% | -1.95% | 35.14% | 14.04% |
| US Dow Jones Industrial 30 | DIA | -3.44% | -1.85% | 39.02% | 25.12% |
| German DAX 40 | DAX | -3.56% | -0.23% | 43.73% | 23.81% |
| UK FTSE 100 | ISFU | -3.38% | 2.08% | 41.75% | 32.83% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -7.40% | -21.12% | 34.66% | 41.06% |
| Hongkong Hang Seng | HSI | -3.32% | -6.17% | 30.92% | 45.08% |
| India NIFTY 50 | INDA | -1.91% | 5.40% | 43.74% | 27.33% |
| Brasil Bovespa | EWZ | -3.15% | 2.53% | 57.51% | 58.86% |
UTHR United Therapeutics vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -3.95% | -2.52% | 37.95% | 12.94% |
| Consumer Discretionary | XLY | -2.26% | 1.47% | 37.42% | 24.96% |
| Consumer Staples | XLP | -4.00% | 0.64% | 40.36% | 32.45% |
| Energy | XLE | -4.26% | -1.62% | 55.41% | 49.98% |
| Financial | XLF | -3.92% | -4.53% | 34.96% | 7.63% |
| Health Care | XLV | -2.82% | 1.74% | 43.11% | 35.15% |
| Industrial | XLI | -2.87% | -3.14% | 38.55% | 14.47% |
| Materials | XLB | -3.30% | -2.18% | 40.93% | 26.90% |
| Real Estate | XLRE | -3.81% | 0.35% | 26.85% | 17.56% |
| Technology | XLK | -4.28% | -3.70% | 34.08% | 13.46% |
| Utilities | XLU | -4.59% | -3.08% | 24.74% | 15.42% |
| Aerospace & Defense | XAR | -2.81% | -3.00% | 31.59% | 15.80% |
| Biotech | XBI | -1.13% | 1.69% | 36.07% | 10.82% |
| Homebuilder | XHB | 1.18% | 3.59% | 36.33% | -12.37% |
| Retail | XRT | -1.23% | 0.18% | 46.00% | 26.17% |
Does United Therapeutics outperform its market, is UTHR a Sector Leader?
Yes, over the last 12 months United Therapeutics (UTHR) made 57.12%, while its related Sector, the SPDR S&P Biotech (XBI) made 46.30%.
Over the last 3 months UTHR made 4.70%, while XBI made -3.08%.
Yes, over the last 12 months United Therapeutics (UTHR) made 57.12%, while its related Sector, the SPDR S&P Biotech (XBI) made 46.30%.
Over the last 3 months UTHR made 4.70%, while XBI made -3.08%.
| Period | UTHR | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -0.85% | -2.54% | 1.46% |
| 3 Months | 4.70% | -3.08% | 4.69% |
| 12 Months | 57.12% | 46.30% | 42.00% |